Carnostatine Hydrochloride is a peptide-like inhibitor scaffold studied for its interactions with carboxypeptidases in biochemical assays. Functional groups mimic substrate termini while resisting full hydrolysis. Researchers analyze inhibition mechanisms, binding geometry, and pH dependence. Applications include enzyme-mechanism elucidation, inhibitor-screening platforms, and structure-activity evaluation.
CAT No: R2757
Synonyms/Alias:Carnostatine (hydrochloride); Carnostatine hydrochloride; SAN9812 (hydrochloride); AKOS040732716; HY-112431A; MS-24186; CS-0103026; G17254; (2S)-2-[[(2S)-4-amino-2-hydroxybutanoyl]amino]-3-(1H-imidazol-5-yl)propanoic acid; hydrochloride
Carnostatine hydrochloride is a synthetic peptide-based inhibitor designed to target specific carboxypeptidase enzymes, notably carboxypeptidase A. As a structurally modified analog, it features a distinctive guanidino group that enhances its binding affinity and selectivity for metallocarboxypeptidases. Its well-characterized mechanism of action, which involves the reversible inhibition of zinc-dependent exopeptidases, makes Carnostatine hydrochloride a valuable biochemical tool for probing proteolytic pathways and enzymatic regulation. Researchers utilize this compound to dissect the functional roles of carboxypeptidases in physiological and pathological contexts, supporting a wide range of studies in enzymology, protein chemistry, and metabolic regulation.
Enzyme inhibition studies: As a potent and selective inhibitor of carboxypeptidase A and related metallocarboxypeptidases, Carnostatine hydrochloride is widely used in enzymatic assays to investigate the catalytic mechanisms and substrate specificities of these proteases. By introducing this inhibitor in vitro, researchers can precisely modulate enzyme activity, allowing for detailed kinetic analyses and the mapping of active site residues. This application is fundamental for elucidating the structural and functional properties of carboxypeptidases, as well as for validating newly discovered enzyme isoforms or engineered variants.
Protease function characterization: The compound serves as a critical probe in studies aiming to define the biological roles of carboxypeptidases within complex proteolytic networks. By selectively inhibiting target enzymes, scientists can observe downstream effects on peptide processing, protein turnover, and regulatory cascades in cell-free systems or tissue extracts. Such experiments provide insight into the physiological significance of carboxypeptidase-mediated reactions, including their contributions to peptide hormone maturation, neuropeptide regulation, and extracellular matrix remodeling.
Peptide substrate mapping: In proteomics and peptide chemistry, Carnostatine hydrochloride is employed to protect peptide substrates from exopeptidase degradation during analytical workflows. Its application ensures the integrity of synthetic or endogenous peptides in experimental setups, facilitating accurate mass spectrometry profiling, sequence analysis, and post-translational modification studies. The ability to selectively block carboxypeptidase activity is particularly valuable in protocols requiring precise peptide mapping or the quantification of labile peptide intermediates.
Metabolic pathway investigation: The inhibitor is instrumental in dissecting metabolic pathways that involve carboxypeptidase-dependent processing steps. By transiently suppressing enzyme function, researchers can identify metabolic bottlenecks, characterize the fate of peptide substrates, and monitor the accumulation of intermediates. Such studies are relevant in fields ranging from amino acid metabolism to peptide-based signaling, where understanding enzyme-substrate relationships is crucial for mapping biosynthetic and degradative routes.
Drug discovery and assay development: Carnostatine hydrochloride is frequently utilized as a reference inhibitor in the screening and validation of novel carboxypeptidase modulators. Its well-defined inhibitory profile provides a benchmark for evaluating the potency and selectivity of new compounds in high-throughput screening assays. Moreover, incorporation of this inhibitor into assay systems enables the development of robust biochemical tests for enzyme activity, inhibitor efficacy, and structure-activity relationship exploration, supporting early-stage drug discovery and lead optimization efforts targeting proteolytic enzymes.
2. TMEM16F and dynamins control expansive plasma membrane reservoirs
3. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More